2019, Number 627
<< Back
Rev Med Cos Cen 2019; 85 (627)
Tuberculosis meníngea
Valle SJ, Romero SA
Language: Spanish
References: 22
Page: 34-39
PDF size: 110.73 Kb.
ABSTRACT
Background: Central Nervous System (CNS) Tuberculosis (TB) is one of the less frequent forms of
extrapulmonary TB, however, it is one of the most devastating forms with high morbidity and
mortality. It represents about 8% of all extrapulmonary cases that occur in immunocompetent
individuals and mortality is estimated at 15-40%.
Methodology / Results: We present the case of a 29-year-old female, with no pathological personal
history, with a subacute headache and constitutional symptoms, who associates dysarthria and
disorientation. At 24 hours after admission, left hemiparesis and a third left cranial nerve are
documented. A molecular study of CSF by M. tuberculosis was carried out, which is positive.
Immediatly started antibiotic treatment associated with steroids but during evolution, it associates
hydrocephalus as an expected complication, requiring a derivation of CSF.
Conclusions: The initial clinical picture of this pathology is nonspecific, characterized by
constitutional symptoms, the most frequent symptoms being fever, headache, vomiting, altered
state of consciousness and cervical stiffness. In more advanced stages of the disease, cranial
nerve involvement (III, IV, VI), focal deficits and visual loss are frequent. The diagnosis is suspected
in the case of chronic lymphocytic meningitis, marked hypoglycorrhachia, requiring visualization
of the smear, demonstration of mycobacterial nucleic acids or isolation of the microorganism by
culture. Imaging studies help in the assessment of differential diagnosis and complications. The
treatment with antifimics consists of a 4-drug phase for 2 months and a 2-drug phase for 7
months..
REFERENCES
Costa Rica Tuberculosis Report, 2017 [Internet]. [cited 2019 Mar 16]. Available from: https://extranet.who.int/sree/Reports?op=Replet&name=%2FWHO_HQ_ Reports%2FG2%2FPROD%2FEXT%2FTBCountryProfile&ISO2=CR&LAN=E N&outtype=html
Thakur K, Das M, Dooley KE, Gupta A. The Global Neurological Burden of Tuberculosis. Semin Neurol. 2018;38(2):226–37.
Brenes Madrigal MY, Marchena Picado M. Epidemiología de la tuberculosis extrapulmonar en el Hospital Rafael Ángel Calderón Guardia: 2009-2013. Rev Médica la Univ Costa Rica. 2014;8(1):39–48.
Be NA, Kim KS, Bishai WR, Jain SK. HHS Public Access. HHS Public Access. 2015;9(2):94–9.
Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: Pathogenesis and clinical aspects. Clin Microbiol Rev. 2008;21(2):243–61.
Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect [Internet]. 2009;59(3):167–87. Available from: http://dx.doi.org/10.1016/j.jinf.2009.06.011
Marais BJ, Heemskerk AD, Marais SS, Van Crevel R, Rohlwink U, Caws M, et al. Standardized methods for enhanced quality and comparability of tuberculous meningitis studies. Clin Infect Dis. 2017;64(4):501–9.
Török ME. Tuberculous meningitis: Advances in diagnosis and treatment. Br Med Bull. 2015;113(1):117–31.
Piccazzo R, Paparo F, Garlaschi G. Diagnostic accuracy of chest radiography for the diagnosis of tuberculosis (tb) and its role in the detection of latent TB infection: A systematic review. J Rheumatol. 2014;41(SUPPL. 91):32–40.
Kulkarni NS, Jaju S. Study of Hematological and Biochemical Parameters in Pulmonary Tuberculosis. 2017;6(9):2015–7.
Leonard JM. Central Nervous System Tuberculosis. Microbiol Spectr. 2017;5(2):44.
Garcia-Monco JC. Tuberculosis. 2014;121:1485–99. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780702040887001000
Organization WH. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. WHO Libr Cat Data [Internet]. 2013;1–7. Available from: http://web.ssaver.gob.mx/citver/
Botha H, Ackerman C, Candy S, Carr JA, Griffith-Richards S, Bateman KJ. Reliability and diagnostic performance of ct imaging criteria in the diagnosis of tuberculous meningitis. PLoS One. 2012;7(6).
Pienaar M, Andronikou S, Van Toorn R. MRI to demonstrate diagnostic features and complications of TBM not seen with CT. Child’s Nerv Syst. 2009;25(8):941–7.
Yu J, Wang Z-J, Chen L-H, Li H-H. Diagnostic accuracy of interferongamma release assays for tuberculous meningitis: a meta-analysis. Int J Tuberc Lung Dis. 2016;20(4):494–9.
Pormohammad A, Nasiri MJ, Fallah F, Pouriran R, Doustdar F, Aghazadeh M, et al. Diagnostic test accuracy of adenosine deaminase for tuberculous meningitis: A systematic review and meta-analysis. J Infect [Internet]. 2017;74(6):545–54. Available from: http://dx.doi.org/10.1016/j.jinf.2017.02.012
Baldwin KJ, Avila JD. Diagnostic Approach to Chronic Meningitis. Neurol Clin [Internet]. 2018;36(4):831–49. Available from: https://doi.org/10.1016/j.ncl.2018.06.004
Figaji A, Mai NTH, Dooley KE, Wilkinson RJ, van Crevel R, Misra UK, et al. Tuberculous meningitis. Nat Rev Neurol [Internet]. 2017;13(10):581–98. Available from: http://dx.doi.org/10.1038/nrneurol.2017.120
Prasad K, Mb S, Ryan H. Corticosteroids for managing tuberculous meningitis ( Review ) SUMMARY OF FINDINGS FOR THE MAIN COMPARISON. 2016;(4):2008–10.
Thwaites GE, Schoeman JF. Update on Tuberculosis of the Central Nervous System: Pathogenesis, Diagnosis, and Treatment. Clin Chest Med [Internet]. 2009;30(4):745–54. Available from: http://dx.doi.org/10.1016/j.ccm.2009.08.018
Soria J, Metcalf T, Mori N, Newby RE, Montano SM, Huaroto L, et al. Mortality in hospitalized patients with tuberculous meningitis. BMC Infect Dis. 2019;19(1):1–7..